Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Jefferies downgrades Softcat to 'underperform'

Fri, 05th Jul 2024 09:15

(Sharecast News) - Analysts at Jefferies downgraded IT infrastructure provider Softcat to 'underperform' on Friday, citing "incremental caution" around the IT services sector.

Jefferies thinks FY24 consensus estimates for Softcat look "reasonable" but noted that FY25-26 consensus of 12-13% underlying earnings growth was already ahead of the company's typical framework to target low double-digit gross profit growth and high single-digit EBIT growth.

"We think this puts downward pressure on consensus," said Jefferies.

The investment bank also noted that Softcat trades on one of the highest valuations in European tech, with valuations that were more consistent with roughly 20-25% EBIT growth.

"Given the forecast risk, this premium valuation looks exposed," said Jefferies. "We align DCF assumptions with the same metrics used at Bytes, leading us to downgrade our price target to 1,490.0p and move our rating to 'underperform'."

Reporting by Iain Gilbert at Sharecast.com

Softcat

Shares in this article

Related News

Citi downgrades Softcat to 'neutral' from 'buy'
15 Jun 2026

Citi downgrades Softcat to 'neutral' from 'buy'

(Sharecast News) - Citi downgraded Softcat to 'neutral' from 'buy' on Monday and lifted the price target to 1,950p from 1,550p as it argued that "even...

LONDON BROKER RATINGS: Exane BNP raises Halma; Shore says 'buy' boohoo
15 Jun 2026

LONDON BROKER RATINGS: Exane BNP raises Halma; Shore says 'buy' boohoo

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Broker Recommendations Halma + 17 more shares
LONDON BRIEFING: Astra gets FDA nod; Frasers bids for Accent Group
15 Jun 2026

LONDON BRIEFING: Astra gets FDA nod; Frasers bids for Accent Group

(Alliance News) - AstraZeneca wins US FDA priority review for kidney drug, while Frasers Group launches a GBP166 million bid for Australian retailer A...

Corporate News Frasers Group + 10 more shares